Walvax Biotechnology Co., Ltd. (SHE:300142)
11.68
+0.52 (4.66%)
Apr 1, 2025, 2:45 PM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 18.68 billion as of April 1, 2025. Its market cap has decreased by -37.37% in one year.
Market Cap
18.68B
Enterprise Value
17.92B
Revenue
3.10B
Ranking
n/a
PE Ratio
152.65
Stock Price
11.68
Market Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 18.68B, an increase of 37.00%. That is a compound annual growth rate of 2.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 309.09B |
Shenzhen Mindray Bio-Medical Electronics | 287.93B |
WuXi AppTec | 194.66B |
Aier Eye Hospital Group | 125.42B |
Zhangzhou Pientzehuang Pharmaceutical., | 122.96B |
Yunnan Baiyao Group Co.,Ltd | 100.54B |
Shanghai United Imaging Healthcare | 100.16B |
Sichuan Biokin Pharmaceutical | 95.03B |